These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 17849025)

  • 21. Health device legislation: an overview of the law and its impact on respiratory care.
    Bancroft ML; Steen JA
    Respir Care; 1978 Dec; 23(12):1179-84. PubMed ID: 10315033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutual recognition of pharmaceutical good manufacturing practice inspection reports, medical device quality system audit reports, and certain medical device product evaluation reports between the United States and the European Community--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(215):60122-64. PubMed ID: 10187390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDA's new regulatory paradigms for in vitro diagnostic devices.
    Robinowitz M; Gutman SI
    Cytotherapy; 1999; 1(4):353-7. PubMed ID: 20426566
    [No Abstract]   [Full Text] [Related]  

  • 24. Medical devices; medical device reporting; baseline reports. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Jun; 73(115):33692-5. PubMed ID: 18677824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review--FDA. Direct final rule.
    Fed Regist; 1998 Apr; 63(80 Pt 1):20530-3. PubMed ID: 10179319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastroenterology-urology devices; effective date of requirement for premarket approval of the penile inflatable implant. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(71):19650-8. PubMed ID: 11010632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. When to conduct a clinical trial.
    Boutrand JP
    Med Device Technol; 2004 Oct; 15(8):28-31. PubMed ID: 16225271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of standards in the review of medical devices.
    Ho C; Jensen D; Lacy F; Muni N; Reilly S; Mallis E
    J Electrocardiol; 2005 Oct; 38(4 Suppl):171-4. PubMed ID: 16226095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical research and the development of new devices: considerations for nurses.
    Lanter J
    Dimens Crit Care Nurs; 2007; 26(3):117-20. PubMed ID: 17440296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDA modernization act of 1997: guidance on medical device tracking; availability--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10640-1. PubMed ID: 10177505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of FDA reform.
    Trunzo J
    Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDA's device inspection lacking. Two reports point to technology, staffing as key culprits.
    Rhea S
    Mod Healthc; 2008 Feb; 38(5):10-1. PubMed ID: 18318369
    [No Abstract]   [Full Text] [Related]  

  • 33. Making sense of the food and drug administration.
    Connor JA
    Semin Pediatr Surg; 2006 Nov; 15(4):293-301. PubMed ID: 17055960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A US FDA medical device update, Part II.
    Donawa ME
    Med Device Technol; 1996 Sep; 7(7):12-6, 18. PubMed ID: 10163518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical devices; procedures for premarket notification, premarket approval, classification, performance standards establishment, banning devices, and availability of regulatory hearings--FDA. Final rule.
    Fed Regist; 1992 Dec; 57(238):58400-6. PubMed ID: 10123143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical devices; humanitarian use of devices--FDA. Direct final rule.
    Fed Regist; 1998 Apr; 63(74):19185-90. PubMed ID: 10178430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs and other product choices.
    Hyman PM; Carvajal R
    Dermatol Ther; 2009; 22(3):216-24. PubMed ID: 19453345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical devices; investigational device exemptions--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(225):64617-26. PubMed ID: 10338870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutual Recognition of the Food and Drug Administration and European Community Member State Conformity Assessment Procedures; pharmaceutical GMP inspection reports, medical device quality system evaluation reports, and certain medical device premarket evaluation reports--FDA. Proposed rule.
    Fed Regist; 1998 Apr; 63(69):17744-71. PubMed ID: 10177764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.